Larvol Delta - Announced-the-enrollment-of-the-rst-patient-in-the-Phase-1b-trial-evaluating-CLR-125-in-refractory-triple-negative-breast-cancer-TNBC

CLR-121125 - Cellectar

https://www.cellectar.com/investors/news-events/press-releases/detail/392/cellectar-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-updates

May 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next